Concepedia

Publication | Closed Access

Neurogranin as a Novel Biomarker in Alzheimer’s Disease

DOI

69

Citations

45

References

2020

Year

Luisa Agnello, Caterina Maria Gambino, Bruna Lo Sasso, Giulia Bivona, Salvatore Milano, Anna Maria Ciaccio, Tommaso Piccoli, Vincenzo La Bella, Marcello Ciaccio
Laboratory Medicine

Abstract

Our findings support the use of CSF neurogranin as a biomarker of synapsis damage in patients with AD.

References

YearCitations

Page 1